XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Equity (Deficit) [Member]
American Well Corporation Stockholder Equity (Deficit) [Member]
Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2022 $ 1,083,851 $ 139 $ 2,162,735 $ (16,969) $ (1,082,028) $ 1,063,877 $ 19,974
Beginning balance (in shares) at Dec. 31, 2022   13,856,791          
Exercise of common stock options 289   289     289  
Exercise of common stock options, Shares   6,429          
Vesting of restricted stock units   $ 1 (1)        
Vesting of restricted stock units, Shares   146,259          
Shares repurchased and retired (1)       (1) (1)  
Shares repurchased and retired,Shares   (15)          
Issuance of stock under employee stock purchase plan 1,268   1,268     1,268  
Issuance of stock under employee stock purchase plan,Shares   25,667          
Stock-based compensation expense 20,997   20,997     20,997  
Currency translation adjustment 2,062     2,062   2,062  
Unrealized gains on available-for-sale securities, net of tax 4,319     4,319   4,319  
Net loss (398,509)       (397,688) (397,688) (821)
Ending balance at Mar. 31, 2023 714,276 $ 140 2,185,288 (10,588) (1,479,717) 695,123 19,153
Ending balance, Shares at Mar. 31, 2023   14,035,131          
Beginning balance at Dec. 31, 2022 1,083,851 $ 139 2,162,735 (16,969) (1,082,028) 1,063,877 19,974
Beginning balance (in shares) at Dec. 31, 2022   13,856,791          
Currency translation adjustment 355            
Unrealized gains on available-for-sale securities, net of tax 3,062            
Net loss (629,128)            
Ending balance at Sep. 30, 2023 519,696 $ 144 2,224,872 (13,552) (1,709,191) 502,273 17,423
Ending balance, Shares at Sep. 30, 2023   14,348,830          
Beginning balance at Mar. 31, 2023 714,276 $ 140 2,185,288 (10,588) (1,479,717) 695,123 19,153
Beginning balance (in shares) at Mar. 31, 2023   14,035,131          
Exercise of common stock options 280   280     280  
Exercise of common stock options, Shares   7,900          
Vesting of restricted stock units   $ 2 (2)        
Vesting of restricted stock units, Shares   171,009          
Shares repurchased and retired (585)       (585) (585)  
Shares repurchased and retired,Shares   (13,233)          
Stock-based compensation expense 21,513   21,513     21,513  
Currency translation adjustment (214)     (214)   (214)  
Unrealized gains on available-for-sale securities, net of tax 1,933     1,933   1,933  
Net loss (93,515)       (92,475) (92,475) (1,040)
Ending balance at Jun. 30, 2023 643,688 $ 142 2,207,079 (8,869) (1,572,777) 625,575 18,113
Ending balance, Shares at Jun. 30, 2023   14,200,807          
Vesting of restricted stock units   $ 1 (1)        
Vesting of restricted stock units, Shares   112,474          
Issuance of stock under employee stock purchase plan 896 $ 1 895     896  
Issuance of stock under employee stock purchase plan,Shares   35,549          
Stock-based compensation expense 16,899   16,899     16,899  
Currency translation adjustment (1,493)     (1,493)   (1,493)  
Unrealized gains on available-for-sale securities, net of tax (3,190)     (3,190)   (3,190)  
Net loss (137,104)       (136,414) (136,414) (690)
Ending balance at Sep. 30, 2023 519,696 $ 144 2,224,872 (13,552) (1,709,191) 502,273 17,423
Ending balance, Shares at Sep. 30, 2023   14,348,830          
Beginning balance at Dec. 31, 2023 480,186 $ 145 2,237,502 (15,650) (1,757,778) 464,219 15,967
Beginning balance (in shares) at Dec. 31, 2023   14,423,903          
Vesting of restricted stock units   $ 3 (3)        
Vesting of restricted stock units, Shares   326,743          
Issuance of stock under employee stock purchase plan 956 $ 1 955     956  
Issuance of stock under employee stock purchase plan,Shares   53,675          
Stock-based compensation expense 16,228   16,228     16,228  
Currency translation adjustment (563)     (563)   (563)  
Net loss (73,449)       (72,105) (72,105) (1,344)
Ending balance at Mar. 31, 2024 423,358 $ 149 2,254,682 (16,213) (1,829,883) 408,735 14,623
Ending balance, Shares at Mar. 31, 2024   14,804,321          
Beginning balance at Dec. 31, 2023 480,186 $ 145 2,237,502 (15,650) (1,757,778) 464,219 15,967
Beginning balance (in shares) at Dec. 31, 2023   14,423,903          
Currency translation adjustment (115)            
Net loss (168,069)            
Ending balance at Sep. 30, 2024 350,050 $ 153 2,275,543 (15,765) (1,923,268) 336,663 13,387
Ending balance, Shares at Sep. 30, 2024   15,287,409          
Beginning balance at Mar. 31, 2024 423,358 $ 149 2,254,682 (16,213) (1,829,883) 408,735 14,623
Beginning balance (in shares) at Mar. 31, 2024   14,804,321          
Vesting of restricted stock units   $ 2 (2)        
Vesting of restricted stock units, Shares   151,734          
Shares repurchased and retired,Shares   (2)          
Stock-based compensation expense 9,838   9,838     9,838  
Currency translation adjustment (4,748)     (4,748)   (4,748)  
Net loss (50,579)       (49,920) (49,920) (659)
Ending balance at Jun. 30, 2024 377,869 $ 151 2,264,518 (20,961) (1,879,803) 363,905 13,964
Ending balance, Shares at Jun. 30, 2024   14,956,053          
Vesting of restricted stock units   $ 2 (2)        
Vesting of restricted stock units, Shares   269,658          
Shares repurchased and retired (1)       (1) (1)  
Shares repurchased and retired,Shares   (154)          
Issuance of stock under employee stock purchase plan 428   428     428  
Issuance of stock under employee stock purchase plan,Shares   61,852          
Stock-based compensation expense 10,599   10,599     10,599  
Currency translation adjustment 5,196     5,196   5,196  
Net loss (44,041)       (43,464) (43,464) (577)
Ending balance at Sep. 30, 2024 $ 350,050 $ 153 $ 2,275,543 $ (15,765) $ (1,923,268) $ 336,663 $ 13,387
Ending balance, Shares at Sep. 30, 2024   15,287,409